- Report
- November 2024
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- January 2024
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2483EUR$2,789USD£2,170GBP
- Report
- October 2024
- 200 Pages
Global
From €4406EUR$4,949USD£3,850GBP
- Report
- May 2023
- 147 Pages
Global
From €4406EUR$4,949USD£3,850GBP
- Report
- May 2023
- 147 Pages
Global
From €4406EUR$4,949USD£3,850GBP
- Report
- March 2023
- 107 Pages
Global
From €3204EUR$3,599USD£2,800GBP
- Report
- August 2024
- 110 Pages
Global
From €3517EUR$3,950USD£3,073GBP
- Report
- May 2024
- 130 Pages
Global
From €3517EUR$3,950USD£3,073GBP
- Report
- November 2023
- 146 Pages
Global
From €3962EUR$4,450USD£3,462GBP
- Report
- June 2024
- 183 Pages
Global
From €4006EUR$4,500USD£3,501GBP
- Report
- January 2023
- 156 Pages
Europe
From €3071EUR$3,450USD£2,684GBP
- Report
- January 2023
- 135 Pages
Africa, Middle East
From €3071EUR$3,450USD£2,684GBP
- Report
- September 2024
- 304 Pages
United States
From €2314EUR$2,599USD£2,022GBP
- Report
- November 2022
- 160 Pages
Global
€3027EUR$3,400USD£2,645GBP
- Report
- October 2023
- 180 Pages
Global
From €1113EUR$1,250USD£972GBP
€2226EUR$2,500USD£1,945GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4318EUR$4,850USD£3,773GBP
- Report
- July 2024
- 90 Pages
China
From €1602EUR$1,800USD£1,400GBP
- Report
- September 2023
- 114 Pages
Global
From €2626EUR$2,950USD£2,295GBP
- Report
- September 2023
- 194 Pages
Global
From €4407EUR$4,950USD£3,851GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more